The Latest Breaking News from WST

English player Jamie O'Neill has paid a heavy penalty at the hands of the World Snooker Tour for turning up at a qualifying match in Leicester under the influence of alcohol

West Pharmaceutical Services Inc (NYSE:WST) reported first-quarter FY22 sales growth of 7.4% year-on-year to $720 million, missing the consensus of $720.92 million. Proprietary products segment revenue grew 10.6% Y/Y to $601.3 million. Contact-manufactured products segment sales declined 6.6% to $118.7 million. Gross profit margin fell 100 basis points to 40%, and the gross…

West Pharmaceutical Services Inc's (NYSE: WST) Q4 net s

Major benchmark stock indexes have been hit hard this month on concerns over high inflation and the Fed’s decision to raise interest rates. However, following fourth-quarter GDP growth, a promising economic outlook should help growth-focused companies perform well this year. Therefore, we think it could be wise to bet on…

A growing demand for early medical diagnosis is driving the market for advanced medical equipment by healthcare centers and hospitals. Also, increasing spending on research & development by medical technology companies to deliver innovative technology is helping the industry rebound. So, we think the recent price dips in the stocks…